UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes

Perkins, BA; Rabbani, N; Weston, A; Adaikalakoteswari, A; Lee, JA; Lovblom, LE; Cardinez, N; (2020) High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes. Scientific Reports , 10 , Article 12709. 10.1038/s41598-020-69350-y. Green open access

[thumbnail of High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabe.pdf]
Preview
Text
High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabe.pdf - Published Version

Download (1MB) | Preview

Abstract

Increased protein glycation, oxidation and nitration is linked to the development of diabetic nephropathy.We reported levels of serum protein glycation, oxidation and nitration and related hydrolysis products, glycation, oxidation and nitration free adducts in patients with type 1 diabetes (T1DM) during onset of microalbuminuria (MA) from the First Joslin Kidney Study, a prospective case–control study of patients withT1DM with and without early decline inGFR. Herein we report urinary excretion of the latter analytes and related fractional excretion values, exploring the link to MA and early decline inGFR.We recruited patients withT1DM and normoalbuminuria (NA) (n= 30) or new onset MA with and without earlyGFR decline (n= 22 and 33, respectively) for this study. We determined urinary protein glycation, oxidation and nitration free adducts by stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC–MS/MS) and deduced fractional excretion using reported plasma levels and urinary and plasma creatinine estimates.We found urinary excretion of pentosidine was increased ca. twofold in patients with MA, compared to normoalbuminuria (0.0442 vs 0.0103 nmol/mg creatinine, P< 0.0001), and increased ca. threefold in patients with early decline inGFR, compared to patients with stableGFR (0.0561 vs 0.0176 nmol/mg creatinine, P< 0.01). Urinary excretion of all other analytes was unchanged between the study groups. Remarkably, fractional excretions of 6 lysine and arginine-derived glycation free adducts were higher in patients with early decline inGFR, compared to those with stableGFR. Impaired tubular reuptake of glycation free adducts by lysine and arginine transporter proteins in patients with earlyGFR decline is likely involved.We conclude that higher fractional excretions of glycation adducts are potential biomarkers for earlyGFR decline inT1DM and MA. Measurement of these analytes could provide the basis for identifying patients at risk of early decline in renal function to target and intensify renoprotective treatment.

Type: Article
Title: High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41598-020-69350-y
Publisher version: https://doi.org/10.1038/s41598-020-69350-y
Language: English
Additional information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharma and Bio Chemistry
URI: https://discovery.ucl.ac.uk/id/eprint/10107767
Downloads since deposit
46Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item